|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Insulin Product Manager
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
6³â¡è |
ä¿ë½Ã |
09.23 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Patient Advocacy Head
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
10³â¡è |
ä¿ë½Ã |
05.20 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Business Insight & Analytics specialist
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
5³â¡è |
ä¿ë½Ã |
09.27 |
|
|
¼¾Æ®·²¸ÞµðÄüºñ½º(ÁÖ) |
¼¿ï,ºÎ»ê Á¶¿µÁ¦ ¿µ¾÷Á÷ ½ÅÀÔ/°æ·ÂºÎ Á÷¿ø ä¿ë
¼¿ï ÀüÁö¿ª, ºÎ»ê ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
04.29 |
|
|
(ÁÖ)¾¾¿£¾Ë¸®¼Ä¡ |
BiostatÆÀ ÀÎÅÏ Ã¤¿ë (BS)
¼¿ï °³²±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
½ÅÀÔ |
ä¿ë½Ã |
06.30 |
|
|
(ÁÖ)ÆÛ½¼ |
ä±Ç°ü¸® ´ã´çÀÚ Ã¤¿ë
¼¿ï ±Ýõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.11 |
|
|
(ÁÖ)À¯Æ¿·º½º |
¹ÙÀÌ¿À »óÀå»ç / Àü·«±âȹ Àü¹®°¡ (´ë¸®~°úÀå±Þ) ¸ðÁý
¼¿ï ±Ýõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÇϹݱ⠻ç¿ø¸ðÁý |
3³â¡è |
ä¿ë½Ã |
10.24 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Diabetes Medical Lead
¼¿ï ¼Ãʱ¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
˂ȍ |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.30 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] QC Project management
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
5³â¡è |
ä¿ë½Ã |
09.30 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Insulin Product Manager
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
6³â¡è |
ä¿ë½Ã |
09.30 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Diabetes Medical Lead
¼¿ï ¼Ãʱ¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
˂ȍ |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.19 |
|
|
¾¾¿£¾Ë¸®¼Ä¡ |
CRO [¾¾¿£¾Ë¸®¼Ä¡] DOÆÀ CDMA ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.04 |
|
|
¾¾¿£¾Ë¸®¼Ä¡ |
ITÆÀ ±âȹÀÚ, °³¹ßÀÚ Ã¤¿ë
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.03 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Public Affairs manager
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
15³â¡è |
ä¿ë½Ã |
06.08 |
|
|
(ÁÖ)½ºÅÙÅØ |
´ëÇü º´¿ø ¿µ¾÷ ¸¶ÄÉÆà Á÷¿ø ä¿ë
¼¿ï ¼ºµ¿±¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.24 |
|